Onera Health has received a €2.5M grant from the European Innovation Council Accelerator for the development of its medical-grade remote care for sleep and chronic patients. According to Eindhoven based Onera, their “home-based solutions will be vital in a post-COVID-19 world”.
Onera’s prime goal is to offer clinical-grade monitoring patches that are “as easy to apply as a band-aid”. Patients can use the monitoring system in their own bed and receive comprehensive sleep care via remote consultations with sleep doctors from the comfort and safety of their homes. 1 in 5 people today struggle with a sleep disorder, Onera’s CTO Ruben de Francisco says. “Eighty percent of those cases remain undiagnosed because conventional sleep testing is expensive, uncomfortable, inconvenient, and even stressful. Our driving mission is to modernize sleep medicine by making sleep services accessible to all, regardless of socioeconomics or geographic location.”
In recent years, basic sleep screening devices such as smartwatches and mattress sensors have captured the public’s fascination, but these gadgets provide limited and inaccurate information about sleep quality De Francisco says. “And because the system monitors brain, lung, and heart functions, the potential for use in other medical fields is great, including utilizing the technology for remote monitoring of a variety of chronic conditions in the post-COVID-19 world.”
Onera has previously raised over €10 million, including Series A funding led by Jazz Pharmaceuticals and imec.xpand, as well as other investors including imec, BOM Brabant Ventures, and 15th Rock Ventures. The European Innovation Council Accelerator is a public funding program for market-creating innovation in disruptive small businesses that have significant growth potential and global ambitions. It is part of Horizon 2020 – the EU’s € 80 billion funding program for Research and Innovation for 2014-2020. De Francisco: “We’re honored that EIC Accelerator has seen the value of our revolutionary technology and innovative approach to remote care. We’ve overcome a lot of challenges to bring hospital-grade monitoring into the home for sleep and chronic disease management.”